Similar to population screening of newborns for over 30 genetic conditions, routine genomic screening for all patients is becoming increasingly viable.
We want to hear from you! Have you noticed if more patients are asking about genetic testing?
Parents want answers following pregnancy loss or perinatal death and genetic testing has the potential to not only determine the cause but also predict the likelihood of a recurrence in future pregnancies.
The largest randomized trial published to date examined whether chromosome screening of select embryos for transfer improves the likelihood of a live birth. Steve Ory, MD, a member of the Contemporary OB/GYN editorial board provides commentary on the findings.
Improved noninvasive testing to detect genetic abnormalities early in pregnancy has been a goal of researchers, and now a team of Australian and Russian biomedical engineers has developed a tiny microfluidic device that could pave the way for such testing.
A recent study designed to reflect clinical practice examined whether preimplantation genetic testing increased live birth rates in women of advanced maternal age.
Women at increased risk for trisomy 21 who have suffered previous miscarriages and have a lower level of education are those most likely to refuse amniocentesis during pregnancy, according to new research.
Mammography is sufficient to predict breast cancer risk in women aged ≥ 60, but in younger women, combining mammography and genetic testing improves the assessment, according to a retrospective case-control study
Gynecologists are faced with a number of hereditary cancer tests. Understanding benefits and limits is key to counseling patients.
Ob/gyns have a responsibility and can no longer be passive in this genomic era.